Class I Recall For Integra’s CereLink Intracranial Pressure Monitors
Executive Summary
The US FDA has labelled a June recall of intracranial pressure monitors from Integra with its most serious designation, class I.
You may also be interested in...
Integra LifeSciences Recalls Products From Boston Facility, Takes Financial Hit
After consulting with the US FDA, Integra Life Sciences initiated a recall of products produced in its Boston Facility. The company expects losses of $22m.
Integra Issues Recall Of Intracranial Pressure Monitors
Integra LifeSciences has recalled CereLink intracranial pressure monitors because of reports they were providing inaccurate readings. The company adjusted its third quarter earnings expectations in response.
FDA Seeks Feedback On Attempt To Modernize Clinical Trials
The US FDA has released a draft guidance from the International Council for Harmonisation that aims to modernize clinical trials. The agency is requesting feedback on the draft, which includes updates on good clinical practices.